Population data provide evidence against the presence of a set point for hemoglobin levels or tissue oxygen delivery by Fitzgerald, Stephen P. et al.
  
 University of Groningen
Population data provide evidence against the presence of a set point for hemoglobin levels or
tissue oxygen delivery
Fitzgerald, Stephen P.; Beverborg, Niels Grote; Beguin, Yves; Artunc, Ferruh; Falhammar,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Fitzgerald, S. P., Beverborg, N. G., Beguin, Y., Artunc, F., Falhammar, H., & Bean, N. G. (2019).
Population data provide evidence against the presence of a set point for hemoglobin levels or tissue
oxygen delivery. Physiological Reports, 7(12), [14153]. https://doi.org/10.14814/phy2.14153
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 13-11-2019
ORIGINAL RESEARCH
Population data provide evidence against the presence of a
set point for hemoglobin levels or tissue oxygen delivery
Stephen P. Fitzgerald1 , Niels Grote Beverborg2,3,4, Yves Beguin5, Ferruh Artunc6,
Henrik Falhammar7,8,9 & Nigel G. Bean10
1 Departments of General Medicine and Endocrinology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
2 Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
3 Department of Medicine-Cardiology, Karolinska Institutet, Stockholm, Sweden
4 Department of Cardiology, University Medical Center Groningen and Rijksuniversiteit Groningen, Groningen, The Netherlands
5 Department of Haematology, CHU de Liege and University of Liege, Liege, Belgium
6 Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University
Hospital T€ubingen, T€ubingen, Germany
7 Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden
8 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
9 Menzies School of Health Research and Royal Darwin Hospital, Tiwi, Northern Territory, Australia






Stephen P. Fitzgerald, Department of General
Medicine and Endocrinology, Royal Adelaide







Received: 8 April 2019; Revised: 25 May
2019; Accepted: 27 May 2019
doi: 10.14814/phy2.14153
Physiol Rep, 7 (12), 2019, e14153,
https://doi.org/10.14814/phy2.14153
Abstract
Hemoglobin levels are believed to be regulated as per a set point model of
regulation. This model of regulation, by which specific levels of a parameter
are targeted and defended by physiological systems, implies a particular popu-
lation correlation between the parameter and its controlling hormone. Empiri-
cal population correlations of other parameters and their controlling
hormones, have denied the presence of such set point-based regulation. To
assess if hemoglobin is regulated according to a set point model we performed
a systematic search of PubMed/MEDLINE and Web of Science identifying rel-
evant reports published up to November 2018. Population hemoglobin/ery-
thropoietin level correlations were retrieved, and these empirically derived
correlations were compared with the positive correlation implied by a set
point model of regulation. Authors of papers containing potentially suitable
data were contacted with requests for further analyses, and a meta-analysis
was performed. Twelve correlations between hemoglobin and erythropoietin
levels from eleven papers were analyzed. None of these correlations were sig-
nificantly positive, three, restricted to the normal range of hemoglobin, were
significantly negative. All but one of the other correlations showed a negative
trend. New analyses of previously published data sets resulted in similar find-
ings. In particular a new analysis of large data sets of males (n = 2417) and
females (n = 2592) with normal range hemoglobin levels, revealed significantly
negative correlations. A meta-analysis of our results indicated that the data
overall are not consistent with a positive relationship between hemoglobin
and erythropoietin (P < 0.0001). Population data indicate that individuals do
not have set point levels of hemoglobin.
Introduction
“Set points” are a fundamental part of models of home-
ostasis (Modell et al. 2015; Goldstein 2017). A “set point”
is a target or ideal level of a parameter which the body
defends by physiological processes, including negative
feedback loops (Romanovsky 2004; Modell et al. 2015).
Set points have been likened to thermostat or cruise con-
trol settings (Modell et al. 2015). A variety of parameters,
including body temperature, blood levels of sodium,
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glucose, and calcium have been described as being so reg-
ulated, that is, as per a “set point model”(Modell et al.
2015).
Hemoglobin and tissue oxygen delivery are also consid-
ered to be regulated as per a set point model (Patel 2008;
Patel et al. 2009; Murphy et al. 2010; Bachman et al.
2014). Certainly, there is little intra-individual (within -
person) variation in hemoglobin levels (Brown and Good-
all 1946). Men and women (Murphy et al. 2010), and
individuals of the same sex across different races/ethnici-
ties (Patel 2008) are considered to have different set
points for hemoglobin.
Alternative models of homeostasis include the “balance
point model” whereby the level of the parameter is not
pre-set but settles at the point of balance of the regulatory
physiological processes (Romanovsky 2004). Conventional
teaching is that cardiac stroke volume is such a parameter
(Klabunde 2005). The “settling point model” (Speakman
et al. 2011) is another model of regulation, this model
again lacking a set point.
The absence of a set point does not imply that parame-
ters homeostatically regulated do not settle around a level
which tends to be stable (Romanovsky 2004).The deter-
mination as to whether a set point exists or not cannot
be readily determined by physiological experimentation.
The stability of the parameter level and the responses of
the associated physiological regulating factors may be
identical with or without the inclusion of a set point in
the model of regulation (Romanovsky 2004).
Studies of population data may be more helpful in this
area. For example it has been argued that the increasing
population prevalence of obesity, the tendency for obesity
to occur in the least affluent members of society, and the
associations of obesity with television watching, marriage
and college attendance all argue against the presence of a
set point that determines weight (Speakman et al. 2011).
Similarly, we have previously shown that a set point
model of regulation implies a particular population (be-
tween -person) correlation between a parameter and its
regulating hormone, that is, the population correlation
should be in the direction of the effect of the controlling
hormone on the parameter (Fitzgerald et al. 2017;
Fitzgerald and Bean 2018a). (The concept of an adjustable
set point (Cabanac 2006) does not affect this property of
a set point model.) For example, if regulation were
according to a set point model, for glucose the popula-
tion correlation should be negative (insulin lowers the
blood glucose level), and for calcium it should be positive
(parathyroid hormone raises the serum calcium level)
(Fitzgerald and Bean 2018a).
The reason why the correlations should be as described
in a set point model is presented fully in our previous
work (Fitzgerald et al. 2017; Fitzgerald and Bean 2018a).
Heuristically, the principle can be understood as follows,
using the subject of this work, the hemoglobin/erythro-
poietin system as the example.
Physiologically, hemoglobin levels are controlled by
erythropoietin via a negative feedback loop (Jelkmann
2011; Bunn 2013). Strictly speaking erythropoietin con-
trols oxygen delivery to tissues (Jelkmann 2011; Bunn
2013), this oxygen delivery being a product of the oxygen
tension and hemoglobin level in the blood. However, in a
normal population of individuals, all living at the same
altitude, there is a uniform oxygen tension in terms of
erythropoietin physiology, and so in these circumstances
erythropoietin is responsible for maintaining hemoglobin
levels (Jelkmann 2011; Heuberger et al. 2013).
According to the set point model, in a physiologically
normal population there will be a range of normal hemo-
globin values, corresponding to a range of normal set
points. There thus will be individuals with either relatively
high or relatively low set points of hemoglobin levels.
Given that the hemoglobin levels are controlled by the
levels of erythropoietin, the only way the physiologically
normal individuals with the relatively high set points of
hemoglobin can attain the high levels of hemoglobin is by
having relatively high levels of erythropoietin, whereas the
individuals with the relatively low set points for hemoglo-
bin must keep their erythropoietin levels relatively low so
as to avoid a hemoglobin level above their set point level.
There is thus generated a positive population, between -
person, relationship between hemoglobin and erythropoi-
etin levels. Note that in each individual in this population
there is still a negative relationship between hemoglobin
and erythropoietin in terms of individual, within-person,
responses to alterations to the hemoglobin level.
Given therefore that the set point model implies a cer-
tain population correlation between a parameter and its
controlling hormone it is possible to test the validity of
the model for any parameter by comparing the implied
correlation with that derived by empirical observation.
Our previous work, using this method of investigation,
indicated that, contrary to conventional teaching, blood
levels of calcium, glucose (Fitzgerald and Bean 2018a)
and thyroxine (Fitzgerald et al. 2017) are not regulated as
per a set point model.
The aim of this study was to determine whether or not
empirical population correlations between hemoglobin
and erythropoietin are consistent with the positive corre-
lation implied by the set point model.
Methods
We systematically reviewed the published literature for
empirical data concerning the population correlation
between hemoglobin and erythropoietin. Furthermore,
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when we found papers describing data and analyses that
did not pertain solely to the normal range we contacted
the authors of these papers and requested further data
and/or analyses.
Search strategy
A systematic search of PubMed/MEDLINE and Web of
Science using terms such as erythropoietin, hemoglobin/
hemoglobin, population, and correlation was conducted
to identify relevant articles published up to November
2018. No restrictions were placed on language, country,
or publication date. Initially the titles of the articles were
screened for relevance and then the abstracts, with full-
text reports of potentially relevant reports reviewed. Addi-
tional relevant articles were searched for in the reference
lists of the retrieved full-text studies. The literature search
was conducted independently by two of the authors (SPF
and HF), and the included and excluded articles were
agreed on by consensus with reference to the criteria
described in the next section.
Study selection and data extraction
Studies reporting on population hemoglobin and erythropoi-
etin level correlations were included. Reports were excluded
if data was not to be considered a reflection of, at least in
part, a normal population (i.e., free of anaemia, poly-
cythemia and disease affecting erythropoietin physiology), or
the studied population was less than 20 individuals. Review
articles, editorials, and meeting abstracts were also excluded.
We extracted from each study the empirically derived
associations between hemoglobin and erythropoietin
levels, the form of the expression of this association (e.g.,
Pearson correlation, slope of line of best fit), and the sta-
tistical significance of any association. The following
information was also extracted from each study: first
author, number of individuals in the population, sex, and
the prevalence of anemia. We did not address the individ-
ual methodology of hemoglobin and erythropoietin mea-
surement on the grounds that any correlations would
remain similar with any valid laboratory method.
The use of a quality assessment (e.g., the Newcastle-
Ottawa Scale; available at: www.ohri.ca/programs/clinica
l_epidemiology/oxford.asp) was considered inappropriate
because these instruments had not been developed for
this setting. The PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) guidelines were
followed (Moher et al. 2009).
Data analysis
The empirically determined correlations were compared
with the positive correlation implied by the set point
model. Only the empiric correlations within the normal
range for the parameter were considered. The evidence
for the correlations within the normal range was consid-
ered strongest when the correlations were separately or
only calculated for data lying within the normal range.
When the line of correlation passed through the normal
range but this line had possibly been affected by consider-
ation also of data lying outside of the normal range we
considered the evidence for the correlations within the
normal range to be less strong.
We performed a meta-analysis of Pearson correlation
coefficients (using metacor from the R-package meta (R
Core Team, 2017; Schwarzer 2007) with Fisher’s z trans-
formation of correlations and a fixed-effects model as
indicated by the in-built test of heterogeneity) and a for-
est plot to test whether the collection of published results
were consistent with a positive relationship between
hemoglobin and erythropoietin. In order to include the
small studies that did not provide Pearson correlation
coefficients we also conducted a more general meta-analy-
sis that did not require Pearson correlation coefficients
per se, merely the sign of the slope of the linear relation-
ship and its statistical significance. To do this we classified
all outcomes in one of four categories:
• positive relationship that is statistically significant,
• positive relationship that is not statistically significant,
• negative relationship that is not statistically significant,
and
• negative relationship that is statistically significant.
We used the conservative null hypothesis of no popula-
tion-level relationship between hemoglobin and erythropoi-
etin (we cannot handle an unspecified positive
relationship) and regarded the different papers as indepen-
dent observations of this relationship. As all the papers had
used a significance level of 5%, the expected proportion of
results to fall in these four categories should be 2.5%,
47.5%, 47.5%, and 2.5%, respectively. We therefore con-
ducted exact multinomial tests (using multinomial.test from
the R package EMT (Menzel 2013)) on all of our results,
regardless of the manner of their reporting, to test whether
they were consistent with the above proportions and hence
the null hypothesis of no relationship.
As our data included analyses which were not restricted
to the normal range of hemoglobin, we also conducted
the same process on the restricted set of analyses that had
been classified as only considering the normal range.
When we in addition obtained new analyses, conducted
on the original data with additional restrictions as to the
normality of subjects, we tested these analyses and also
tested the combination of the results from the systematic
review, restricted to the normal range of hemoglobin, and
the results of the new analyses.
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Results
The systematic search identified 144 potentially relevant
records. Another study was identified through review of
the reference lists. After removal of duplicates, 104
records were screened for eligibility, identifying eleven
data sets suitable for analysis (Beguin et al. 1991, 1993;
Carretti et al. 1993; Schrieber et al. 1996; Charuruks et al.
2000; Roque et al. 2001; Fehr et al. 2004; Ershler et al.
2005; Artunc and Risler 2007; Mercadal et al. 2012; Grote
Beverborg et al. 2015) (Fig. 1). Three studies were most
suitable as they specifically examined the normal range
(Beguin et al. 1991; Charuruks et al. 2000; Mercadal et al.
2012). We found one further report (Ershler et al. 2005)
dealing with the normal range but measures of signifi-
cance were not supplied. We included a small study con-
cerning erythropoietin in pregnant individuals (Carretti
et al. 1993) accepting that these subjects may, or may not
be considered normal. We also found six studies that
included a correlation for hemoglobin and erythropoietin
through the anemic and normal ranges (Beguin et al.
1993; Schrieber et al. 1996; Roque et al. 2001; Fehr et al.
2004; Artunc and Risler 2007; Grote Beverborg et al.
2015).We did not include two further studies (Malagar-
nera et al. 1996; Panjeta et al. 2017) reporting correla-
tions between renal function and erythropoietin, and
renal function and hemoglobin but not directly between
hemoglobin and erythropoietin.
All of the above data sets had originally been developed
for reasons unrelated to the topic of this paper.
The results of our literature search are summarized in
Table 1.
None of the five studies (including the study of preg-
nant women) specifically examining the normal range, or
the six studies examining the normal range in conjunc-
tion with the anemic range, revealed a significantly posi-
tive correlation between hemoglobin and erythropoietin.
Significantly negative correlations were found. None of
the studies therefore support the existence of a set point
for hemoglobin and each of the data sets, to a greater or
lesser extent, are in fact inconsistent with the existence of
such a set point. By contrast, all of the data sets are con-
sistent with a balance point model of hemoglobin regula-
tion.
We were able to have further analyses performed on
three of the above-mentioned studies by the original
authors (Table 2). The results were qualitatively similar.
When considering the normal range of hemoglobin, the
two smaller studies (Beguin et al. 1991; Artunc and Risler
2007) between them showed non-significant negative cor-
relations. One of these re-analyses (Beguin et al. 1991)
reconsidered the analysis performed earlier, rather than
examining a significantly different sub-group. To avoid
double counting, only this second analysis was considered
when we performed a meta-analysis including studies
from both Tables 1 and 2.
More importantly re-examination of Grote Beverborg’s
large general population study (Grote Beverborg et al.
2015) revealed highly significant (P < 0.001) negative cor-
relations between hemoglobin and erythropoietin in indi-
viduals of both sexes with normal range haemoglobin
levels (Table 2, Figs. 2 and 3). Furthermore, the highly
significant negative correlation persisted when the popula-
tions were restricted by excluding the presence of any of
a number of complicating medical conditions (Table 3).
Finally, as the lower limit of hemoglobin was raised to
exclude the possibility of ever more subtle disease the
negative correlations persisted albeit with attenuated sig-
nificance (Table 3).
When we subjected our results to correlation coefficient
meta-analysis we were only able to combine the studies
that provided Pearson correlation coefficients. Including
only the studies on individuals with normal hemoglobin
from Table 1 resulted in a non-significant negative corre-
lation. When the data were enriched by the new analyses
in Table 2 we found a confidence interval for the correla-
tion to be 0.1269 to 0.0747, P < 0.0001. A forest plot
(Fig. 4) confirmed the negative correlation overall.
The small studies that did not provide Pearson correla-
tion coefficients provided results in the same direction as
the overall value and their inclusion would not be
expected to materially change the results. In particular the
only study so missing from analysis of studies pertaining
solely to the normal hemoglobin range was that of Ershler
et al. (2005) which reported a significantly negative corre-
lation.
The exact multinomial tests conducted on all of our
results, regardless of the manner of their reporting, con-
firmed our coefficient meta-analyses and forest plot. We
first considered all of the results from Table 1 and found
P < 0.0001. Consideration of only the results from
Table 1 pertaining to the normal range resulted in
P = 0.013. The analysis of results from Table 2 resulted
in P = 0.0039 and examination of all the results from
Tables 1 and 2 pertaining to the normal range only,
resulted in P < 0.0001. Thus, we consistently reject the
null hypothesis of no population-level relationship and
are therefore left with the alternative hypothesis that there
is in fact a negative population-level relationship between
hemoglobin and erythropoietin.
Discussion
We have found that the literature generally states that
there is a set point for hemoglobin (Patel, 2008; Patel
et al. 2009; Murphy et al. 2010; Bachman et al. 2014 )
2019 | Vol. 7 | Iss. 12 | e14153
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and that the physiological correlation between hemoglo-
bin and erythropoietin is negative (Beguin et al. 1991;
Carretti et al. 1993). It has not been appreciated that
these two premises are mutually exclusive. The under-
standing of the negative correlation has been based on
small studies and on studies combining normal subjects
with those with abnormal hemoglobin levels.
The new analyses we have presented provide stronger
evidence of the negative population correlation between
hemoglobin and erythropoietin within the normal range.
Our work thereby also provides evidence against the pres-
ence of a set point for hemoglobin. Our conclusion
applies equally to the parameter of tissue oxygen delivery.
Therefore these parameters may be added to a list that
includes body temperature, and blood levels of thyroxine,
glucose, and calcium, of parameters unlikely to be regu-
lated as per a set point model.
The methodology and logic of this current work is sim-
ilar to that of our previously published work (Fitzgerald
et al. 2017; Fitzgerald and Bean 2018a). This work differs
in that addition to reviewing the literature we were able
to generate new correlations by re-analysis of previously
presented data. The eleven data sets upon which we base
our conclusions regarding hemoglobin and erythropoietin
provide strong evidence. In a set point model, as allowed
by statistical variation, all data sets should be consistent
with the model; thus, even if additional data sets were
discovered to have a positive relationship and hence be
consistent with a set point model, the data sets we found
would still stand as evidence against the existence of a
hemoglobin set point. Our general meta-analysis, using
the exact multinomial tests, is very conservative as the
null hypothesis was the absence of a correlation rather
than a positive correlation.
























Additional records identified 
through other sources 
(n = 1)







assessed for eligibility 
(n = 16)
Full-text articles excluded 
(n = 4)
Elderly (n = 1)
No adequate or no 
correlation reported (n = 
3)
Studies included in 
qualitative synthesis 
(n = 11)
Studies included in 
quantitative synthesis 
(n = 11)
Figure 1. Flowchart illustrating the procedure for article inclusion and exclusion in a systematic review of set point for hemoglobin level. A
systematic search of PubMed/MEDLINE and Web of Science up to November 2018, with manual searching of reference lists, identified only 11
relevant reports.
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The studies that considered the correlation between
hemoglobin and erythropoietin across the anemic and
normal ranges concurrently potentially might be showing
a negative correlation across the normal range on account
of the points in the anaemic range. Nevertheless even
within these studies there is some evidence of a negative
relationship, and no strong evidence of a positive rela-
tionship, within the normal range. In particular the corre-
lation between hemoglobin and erythropoietin remained
negative in populations with high numbers of individuals
with normal hemoglobin levels and minimal numbers of
significant anaemia. It seems implausible that the low
numbers of anaemic individuals could change a popula-
tion correlation not just from a positive correlation to no
correlation, but further to a negative correlation.
The studies that specifically examined the normal
range, and most particularly the re-analysis of Grote
Beverborg’s data sets (Grote Beverborg et al. 2015),
Table 1. Summary of published studies indicating a correlation between hemoglobin (Hb) and Erythropoietin (Epo)
Author/year Population
Sex M = male,









S = slope log
Epo vs Hb Significance
Charuruks et al. (2000) Blood donors F/100/0 Y r = +0.015 NS
M/100/0 Y r = 0.289 P < 0.01
Mercadal et al. (2012) GFRa >30 M and F/204/0 Y r = 0.05 P = 0.58









Y (Hct > 40%) S = 0.003 NS







N power = 2 P < 0.001
Roque et al. (2001) Healthy volunteers M and F/100/50 N S = 0.04275 P < 0.0001
Fehr et al. (2004) CClc >40 M 60%/289/119 anemia
(Hb < 13G/dL)
N r = 0.35 P < 0.001
Artunc and Risler (2007) Anemia work-up/No CKDd M 49%/167/21% anemia N S = 0.135 P < 0.0001
Schrieber et al. (1996) No IBDe (controls) Not specified/42/18 anaemia N S = 0.0522 P < 0.001
Beguin et al. (1991) Normal + anemia Not Spec./166/82 anemia N S = 0.0695 P = 0.000
aGlomerular filtration rate.








Y = Yes, N = No




General population Male/2417 Y (14–17.5 g/dL) r = 0.084 P < 0.0001
Female/2592 Y (12.3–15.3 g/dL) r = 0.1174 P < 0.0001
Artunc and
Risler (2007)
Non anaemic subset of
total sample
Not specified/29 Y (12–16 g/dL) r = 0.2868 P = 0.5167
Beguin et al.
(1993)
Reference set Not specified/21 Y (Hct 38.5–51) r = 0.0493a P = 0.83
aCorrelation with Hct rather than Hb.
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provide the strongest evidence of a negative correlation
between hemoglobin and erythropoietin. Grote Bever-
borg’s re-analysis approaches an ideal study, and might
well stand on its own. It is large, the analysis is restricted
to normal individuals as strictly defined, and in particular
excludes individuals with conditions likely to interfere
with the assessment of the normal relationship between
hemoglobin and erythropoietin. It also includes support-
ing sensitivity analyses. The previously available analyses
restricted to normal individuals, were hampered by, a less
strict definition of normal, the limited analyses, and/or
the small sizes of the population studied.
The totality of evidence therefore points to a negative
relationship between hemoglobin and erythropoietin
which strengthens from the normal range into the anemic
range.
Our conclusions rely on the validity of the empiric
data. It would, however, require great corruption of the
normal range data, for example, via a proposal that the
normal range is corrupted by great numbers of pathologi-
cal individuals not at set point, to reverse the correlations.
Any corruption based on significant cardiorespiratory
conditions affecting tissue oxygen delivery would tend to
strengthen a positive population correlation between
hemoglobin and erythropoietin rather than reverse it. Any
corruption in terms of occult anemia would need to be in
all data sets, including Grote Beverborg’s carefully selected
reference sets (Grote Beverborg et al. 2015), and resist
our progressive lifting of the lower limit of the examined
hemoglobin range.
There is however no reason to posit such a proposition
of data corruption, which would also negate all the previ-
ous work suggesting that hemoglobin set points differ
across sex and race, just as there is no reason to propose
unidentified physiological mechanisms that also might
alter population correlations.
It is interesting that of all of the data sets we have now
found, for thyroxine (Fitzgerald et al. 2017), glucose and
calcium (Fitzgerald and Bean 2018a), as well as for hemo-
globin, none have revealed correlations supportive of a set
point model. The correlations of the larger studies have
not contradicted the set point model by being merely neu-
tral; they have tended to be significantly in the opposite
direction to that implied by the model. The fact that the
evidence for all these parameters is inconsistent with set
point based physiology also supports the evidence for
each; that is, the evidence we have presented regarding the
regulation of hemoglobin does not represent a physiologi-
cal or statistical aberration. To gainsay the totality of evi-
dence one must posit that not only the normal range for
hemoglobin is corrupted or that there are other unidenti-
fied physiological processes at play in this system, but that
the same applies for the other parameters.
The pattern of population correlations suggests in fact
that there is a general pattern in physiological regulation,
by which the population variation in the controlling hor-
mone physiology (e.g., erythropoietin response to hemo-
globin), is less than the population variation in the
parameter physiology (e.g., hemoglobin response to ery-
thropoietin) (Fitzgerald and Bean 2016). In the circum-
stance of a given variation in parameter physiology, such
an arrangement leads to a minimisation in intra-, and
inter-individual variation in parameter levels (Fitzgerald
and Bean 2018b). Such an outcome is particularly advan-
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Hemoglobin (g/dL) NC2
Men with Hb 14.0 - 17.5
Figure 2. Scatter plot of simultaneous hemoglobin and
erythropoietin levels, restricted to hemoglobin values in the normal
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Hemoglobin (g/dL)
Women with Hb 12.3 - 15.3
Figure 3. Scatter plot of simultaneous hemoglobin and
erythropoietin levels, restricted to hemoglobin values in the normal
range, in women of the general population study of Grote
Beverborg et al. (2015).
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In conclusion, the evidence indicates that individuals
do not have set point levels of hemoglobin. Apart from
the clarification of the physiology of individual parame-
ters, the progressive discovery of parameters not regulated
as per a set point model, casts increasing doubt on the
concept that regulation by a set point model is the norm
in physiology.
This clarification does not affect the validity of other
work detailing the physiological mechanisms involved in
homeostasis or important in adaptive physiology (for
example adaptation to altitude). In particular our work
does not contradict the evidence that erythropoietin levels
rise in the event of a drop in hemoglobin levels such that
a stable level of hemoglobin is restored. Our work does
aid physiological research as it explains the difficulties
finding the physiological substrates of set points (Modell
et al. 2015). It enables clearer explanations as to why
hemoglobin levels tend to differ between sexes and races.
It also re-frames the discussion of normal ranges of vari-
ous parameters, for example, there is no need to propose
that an individual has an individually set level of a
parameter such that the individual is disadvantaged by a
shift from this level even though this shifted level may
still lie within the population normal range (Andersen
et al. 2002).
Further practical consequences of this advance in the
comprehension of the fundamental outline of physiologi-
cal regulation may emerge.
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